加用小剂量阿托品治疗重度急性发作期哮喘的临床观察  

Clinical observation of low dose atropine on treating severe acute asthma

作　　者：王开云[1] 苟升东 王海霞[1] 吴炬[1] 刘建红[1] 彭亚岚[1] 

机构地区：[1]攀枝花市第二人民医院呼吸科,四川攀枝花617068

出　　处：《现代医药卫生》2010年第1期22-23,共2页Journal of Modern Medicine & Health

摘　　要：目的:观察小剂量阿托品治疗重度急性发作期哮喘的临床疗效。方法:将43例重度急性发作期哮喘患者随机分成对照组和实验组,对照组采用常规治疗,实验组在此基础上加用小剂量阿托品(0.5 mg肌内注射两次间隔12小时)。观察患者疗效及临床表现缓解时间。结果:实验组与对照组临床疗效差异无显著性(P>0.05)。临床表现缓解时间有明显差异(P<0.05)。结论:加用小剂量阿托品治疗可以更快缓解重度急性发作期哮喘临床表现。Objective ：To observe the clinical efficacy of low-dose atropine in the treatment of severe acute asthma.Methods：We randomly divided 43 cases of severe acute asthma into control group and experimental group.The control group on conventional treatment. The experimental group was given low dose atropine treatment on basis of conventional treatment （intramuscular injection ,0.5mg twice daily,interval 12h）.We observed the clinical efficacy and clinical remission time.Results：There was no significant difference in the treatment effect （P〉0.OS）.Time to alleviate clinical manifestation was significantly different （P〈0.05）.Conclusion： Low-dose atropine treatment can alleviate more quickly clinical manifestation of patients with severe acute stage of asthma.

关 键 词：阿托品 哮喘 治疗 

分 类 号：R5[医药卫生—内科学]